Dendritic cell vaccine as a potential strategy to end the COVID-19 pandemic. why should it be Ex Vivo?
Description
INTRODUCTION: Developing a safe and efficacious vaccine that can induce broad and long-term immunity for SARS-CoV-2 infection is the most critical research to date. As the most potent APCs, dendritic cells (DCs) can induce a robust T cell immunity
